In the TME, overexpressed CD47 on cancer cells bind to SIRPα on myeloid cells, especially macrophages, monocytes, granulocytes, and CD4+ DCs, limiting phagocytosis and intracellular degradation [290]. This evidence concerns the gene SIRPA and cancer.